http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017000400-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8b5dba89fde22f36240d44eed6c43c5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-165
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-16
filingDate 2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11874d627641f8bfad4ac1efc6fca1a1
publicationDate 2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017000400-A1
titleOfInvention Biomarkers For The Prediction Of Treatment Outcomes In ADHD
abstract The present invention relates to the field of biomarkers and in particular to their utilisation in treatment. Embodiments of the invention have been particularly developed as biomarkers enabling optimisation of treatment regimes and as uses of the biomarkers in tests for the prediction of optimised treatments and treatment outcomes in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. The invention will be described hereinafter with reference to this application. However, it will be appreciated that the invention is not limited to this particular field of use.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108542404-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020144575-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707217-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021196175-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111919261-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020054618-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021219894-A1
priorityDate 2014-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005273017-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420765
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226489731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1480

Total number of triples: 48.